COVID-19 vaccination with bacterial peptide conjugated to receptor-binding domain elicits potent immune response

By | July 7, 2022
In a new study, researchers assessed the efficiency of immunization with a bacterial peptide conjugated to the SARS-CoV-2 receptor-binding domain against SARS-CoV-2 infection.